Pseudoleprechaunism syndrome, Patterson type

Pseudoleprechaunism syndrome, Patterson type (also known as Patterson syndrome or Patterson pseudoleprechaunism) is an extremely rare genetic disorder characterized by features that superficially resemble leprechaunism (Donohue syndrome) but represent a distinct clinical entity. The condition was first described by Patterson and Watkins in 1962. Key clinical features include progressive lipodystrophy (abnormal distribution or loss of body fat), bronze skin hyperpigmentation resembling Addisonian pigmentation, skeletal abnormalities including cortical thickening of long bones and cranial hyperostosis, and adrenal cortical hyperplasia. Affected individuals may also present with hepatomegaly (enlarged liver), intellectual disability, and distinctive facial features. The endocrine system is notably affected, with adrenocortical dysfunction being a prominent feature. The condition affects multiple body systems including the integumentary (skin), skeletal, endocrine, and central nervous systems. Cutaneous bronzing typically develops progressively during childhood. The skeletal manifestations include periosteal thickening and sclerosis of the long bones and skull. Growth abnormalities and abnormal body proportions may also be observed. Given the extreme rarity of this condition, with only a handful of cases reported in the medical literature, there is no established specific treatment. Management is supportive and symptomatic, focusing on addressing individual clinical manifestations such as endocrine abnormalities and developmental support. Monitoring of adrenal function and skeletal complications is recommended. Genetic counseling is advised for affected families.

Common questions about Pseudoleprechaunism syndrome, Patterson type